Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Brij 92
2. Brij 96
3. Brij 97
4. Brij 98
5. Brij 99
6. El620
7. Emulgin Ro-40
8. Peg 20 Oleyl Ether
9. Polyethylene Glycol Oleyl Ether
10. Polyoxyethylated Vegetable Oil
11. Volpo 20
1. 5353-25-3
2. 2-[(z)-9-octadecenyloxy]ethanol
3. Emulphor On-870
4. Brij 98
5. Oleth-20
6. Oleth-23
7. Oleth-10
8. El-620
9. Polyoxyethylene (6) Oleyl Ether
10. 2-(9-octadecenyloxy)ethanol (z)
11. Ethanol, 2-(9-octadecenyloxy)-, (z)-
12. Dsstox_cid_7714
13. Brij97
14. Dsstox_rid_78547
15. Dsstox_gsid_27714
16. 2-cis-9-octadecenyloxyethanol
17. Schembl285467
18. Qspl 139
19. Chembl3183983
20. Polyoxyethylene (20) Oleylether
21. Dtxsid30858839
22. Tox21_200128
23. Zinc72186740
24. Poly(oxy-1,2-ethanediyl), .alpha.-(9z)-9-octadecenyl-.omega.-hydroxy-
25. 2-[(9z)-9-octadecenyloxy]ethanol #
26. 2-[(z)-9-octadecen-1-yl)oxyethanol
27. 2-[(9z)-9-octadecen-1-yloxy]ethanol
28. Ethanol, 2-(9-octadecenyloxy)-,(z)-
29. Ncgc00248533-01
30. Ncgc00257682-01
31. As-83051
32. Cas-9004-98-2
Molecular Weight | 312.5 g/mol |
---|---|
Molecular Formula | C20H40O2 |
XLogP3 | 7.3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 18 |
Exact Mass | 312.302830514 g/mol |
Monoisotopic Mass | 312.302830514 g/mol |
Topological Polar Surface Area | 29.5 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 214 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 365
Submission : 1960-03-03
Status : Inactive
Type : IV
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 365
Submission : 1960-03-03
Status : Inactive
Type : IV
ABOUT THIS PAGE
A Emulphor manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Emulphor, including repackagers and relabelers. The FDA regulates Emulphor manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Emulphor API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Emulphor supplier is an individual or a company that provides Emulphor active pharmaceutical ingredient (API) or Emulphor finished formulations upon request. The Emulphor suppliers may include Emulphor API manufacturers, exporters, distributors and traders.
click here to find a list of Emulphor suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Emulphor DMF (Drug Master File) is a document detailing the whole manufacturing process of Emulphor active pharmaceutical ingredient (API) in detail. Different forms of Emulphor DMFs exist exist since differing nations have different regulations, such as Emulphor USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Emulphor DMF submitted to regulatory agencies in the US is known as a USDMF. Emulphor USDMF includes data on Emulphor's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Emulphor USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Emulphor suppliers with USDMF on PharmaCompass.
Emulphor Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Emulphor GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Emulphor GMP manufacturer or Emulphor GMP API supplier for your needs.
A Emulphor CoA (Certificate of Analysis) is a formal document that attests to Emulphor's compliance with Emulphor specifications and serves as a tool for batch-level quality control.
Emulphor CoA mostly includes findings from lab analyses of a specific batch. For each Emulphor CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Emulphor may be tested according to a variety of international standards, such as European Pharmacopoeia (Emulphor EP), Emulphor JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Emulphor USP).
LOOKING FOR A SUPPLIER?